These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28929818)

  • 1. Improving accountability in vaccine decision-making.
    Timmis JK; Black S; Rappuoli R
    Expert Rev Vaccines; 2017 Nov; 16(11):1057-1066. PubMed ID: 28929818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core values for vaccine evaluation.
    Timmis JK; Rigat F; Rappuoli R
    Vaccine; 2017 Jan; 35 Suppl 1():A57-A62. PubMed ID: 28017445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making?
    Kapiriri L; Norheim OF; Martin DK
    Soc Sci Med; 2009 Feb; 68(4):766-73. PubMed ID: 19070414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
    Angelis A; Kanavos P
    Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health.
    Kaslow DC; Kalil J; Bloom D; Breghi G; Colucci AM; De Gregorio E; Madhavan G; Meier G; Seabrook R; Xu X
    Vaccine; 2017 Jan; 35 Suppl 1():A10-A15. PubMed ID: 28017438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance toward the implementation of multicriteria decision analysis framework in developing countries.
    Inotai A; Nguyen HT; Hidayat B; Nurgozhin T; Kiet PHT; Campbell JD; Németh B; Maniadakis N; Brixner D; Wijaya K; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):585-592. PubMed ID: 30092151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea.
    Kwon SH; Park SK; Byun JH; Lee EK
    Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):411-419. PubMed ID: 28019130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations relating to healthcare resource allocation decisions.
    Olver I; Dodds S; Kenner J; Kerridge I; McGovern K; Milligan E; Mortimer R;
    Intern Med J; 2019 Nov; 49(11):1364-1367. PubMed ID: 31713342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involving patients, the insured and the general public in healthcare decision making].
    Mühlbacher AC; Juhnke C
    Z Evid Fortbild Qual Gesundhwes; 2016; 110-111():36-44. PubMed ID: 26875034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involving decision-makers in the research process: Challenges of implementing the accountability for reasonableness approach to priority setting at the district level in Tanzania.
    Maluka S; Kamuzora P; Ndawi B; Hurtig AK
    Glob Public Health; 2014; 9(7):760-72. PubMed ID: 24921238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.
    Whitty JA; Littlejohns P
    Health Policy; 2015 Feb; 119(2):127-36. PubMed ID: 25267072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transparency in public health decision-making].
    García-Altés A; Argimon JM
    Gac Sanit; 2016 Nov; 30 Suppl 1():9-13. PubMed ID: 27837801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study.
    Wagner M; Samaha D; Casciano R; Brougham M; Abrishami P; Petrie C; Avouac B; Mantovani L; Sarría-Santamera A; Kind P; Schlander M; Tringali M
    Int J Health Policy Manag; 2019 Jul; 8(7):424-443. PubMed ID: 31441279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.